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Abstract 
Porcine Circovirus Type 1 (PCV1) is a member of the Circoviridae family containing 
a single-stranded circular genome. The protein encoded by its third open reading frame 
(PCV1 VP3) has displayed onco-specific induction of apoptosis. Localization signals within 
homologues of PCV1 VP3 have been implicated in this onco-specific activity. Through the 
use of prediction algorithms two putative nuclear export sequences (NES) have been found in 
PCV1 VP3. Site-directed mutagenesis was applied to target specific amino acids and assess 
the functionality of these two export sequences. The strong cytoplasmic localization observed 
after the NES mutations raise many questions as to the functionality of these classical export 
sequences as well as the possible existence of non-classical sequences within PCV1 VP3.  
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Introduction  
A staggering percentage of the American population will develop cancer at some 
point in their lifetime. The American Cancer Society predicts that 50% of men and 33% of 
women will receive this life-changing diagnosis. While there are many different types of 
cancer, all forms originate from cells that have lost the ability to control the cell cycle. This 
transformation results in the proliferation of cells with damaged DNA that plague the body 
either through the growth of tumors or invasion of other tissues24. 
The body has many mechanisms to prevent cancer, but a key gene that plays a 
significant role in protecting the cell cycle is TP53. This tumor suppressor gene codes for the 
tumor  suppressor  protein  p53.  This  protein,  nicknamed  the  “guardian  of  the  genome”  detects  
both cellular and genetic damage. This tumor suppressor is able to activate various pathways 
to prevent abnormal cell growth; it can activate DNA repair, cell cycle arrest, and the 
induction of apoptosis. However, mutations as simple a missense mutation can result in loss 
of functional p53 leading to the development of tumorigenesis22. 
 Mutations in p53 are incredibly common among cancer patients. These mutations 
may lead to tumorigenesis but they can also develop in later stages of cancer. Mutations in 
the TP53 gene are seen in almost all types of cancer and over half of the patients suffering 
with this disease lack functional p53. Unfortunately, many chemotherapeutic agents and 
radiation manipulate apoptotic pathways, which require functional p53. The apoptotic death 
induced by p53 determines the side effects of treatment in many cell types. The activation of 
p53 with radiation and cytostatic drugs is considered the most direct and promising anti-
cancer strategy. However, it is not favorable for normal tissues because it causes genotoxic 
stress by direct DNA damage and inhibits the cell from undergoing normal mitosis8. 
Considering the overwhelming population of cancer patients who lack functional p53, 
it is crucial to find p53-independent treatments. A solution may reside in the third viral 
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protein (VP3) coded by select members of the Circoviridae family. Research has shown that 
these proteins have the ability to induce apoptosis within cancer cells, leaving healthy cells 
intact; furthermore it does so in a p53-independent manner. This has drawn attention to this 
viral protein family and promoted research concerning VP3 characterization, particularly 
focused on the onco-apoptotic capability. 
The Circoviridae family, classified as a member of the Circovirus genus, contains 
non-enveloped viruses with icosahedral symmetry that have a single-stranded circular DNA 
genome4. These viruses have different characteristics and varying levels of pathology 
depending on the host, but have several similarities in structure and function. One strain of 
virus in the Circovirus genus is the Porcine Circovirus (PCV). PCV has two types, PCV1 and 
PCV2, which have different mechanisms and virulence in swine. 
The investigation of PCV became more prevalent after its isolation as a contaminant 
in the porcine PK-15 cell line in 197413,25. While the contamination did not have detrimental 
effects on the cells, it did contaminate any viral stocks produced using the PK-15 cell line. 
While it is possible that PCV was a contaminant of serum used during cell culture, it is more 
likely that the virus was present among the original PK-15 cells. It has been found that the 
presence of PCV is common among swine populations in North America and Europe.  
PCV gained further attention after the discovery that PCV2 was the primary cause of 
postweaning multisystemic wasting syndrome (PMWS) in swine populations. This disease 
can cause interstitial pneumonia, dyspnea, emaciation, and enlarged lymph nodes among 
other side effects6. PCV1 is nonpathogenic within a porcine host, but it has also gained recent 
attention. In 2010, PCV1 was found to be a contaminate in pediatric rotavirus vaccines. The 
FDA announced that due to the nonpathogenic history of PCV1, the vaccines are still 
considered to be safe. Although companies are allowed to continue selling the contaminated 
vaccines, many have decided to remanufacture their products. 
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Although PCV1 and PCV2 differ in virulence, they share a high degree of homology 
on the nucleotide level. They contain approximately 75% of the same nucleotide sequence 
and have similar open reading frames (ORFs)25. The two main ORFs in both viruses, ORF1 
and ORF2, code for the rolling circle replication initiator protein gene (rep) and capsid 
protein gene (cap), respectively. The rep gene encodes two viral replication-associated 
proteins Rep and Rep' and is transcribed in a clockwise direction. The cap gene encodes the 
immunogenic capsid protein, which is located in the complementary viral strand. Between 
these ORFs is an intergenic area that contains the origin of replication and is characterized by 
a putative stem-loop structure4.  
 
Figure 1: Genomic layout of PCV1 
 
While the two viruses share a high degree of homology, a significant piece of data 
concerning their most variable region was recently discovered. The most variable coding 
region of the PCVs is the third open reading frame (ORF3), which codes for the third viral 
The first two open reading frames (ORF1 and ORF2) of PCV1 are located on either side of 
the origin of replication and are transcribed divergently. The third open reading frame 
(ORF3) of PCV1 is 621 nucleotides in length and overlaps ORF1, although it is transcribed 
in the opposite direction.  
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protein (VP3). This genomic sequence codes for a protein with apoptosis inducing abilities 
and creates the greatest variance between PCV1 VP3 and PCV2 VP3. While PCV2 VP3 is 
only 104 amino acids long, PCV1 VP3 contains 206 amino acids, almost double the length of 
PCV2 VP33. The highly conserved amino acids (1-104) of PCV1 VP3 shall be considered the 
core domain from this point forward, while the extension of the C-terminus of PCV1 VP3 
shall be referred to as the tail domain. This unique tail domain has yet to be characterized 
based on its role in killing capacity and genetic variance. 
It has been found that VP3 is a highly conserved sequence in PCV and the chicken 
anemia virus (CAV), another member of Circoviridae family. The CAV VP3 has been 
isolated and found to contain onco-specific activity, which has led many researchers to 
suspect that other Circoviridae VP3 family members may have similar traits18. Since the 
apoptotic  ability  of  CAV’s  VP3  in  transformed  human  cells is so significant, it was named 
Apoptin10. Apoptosis is a complicated process that can be induced through various 
mechanisms. Due to the many pathways available to induce programmed cell death, the 
manipulation of apoptotic pathways is involved in a variety of diseases, including cancer.  
Apoptosis may be induced through two separate pathways: extrinsic and intrinsic. 
Both of these pathways induce a protease cascade through the activation of caspases, which 
are proteases that induce apoptosis.  The  extrinsic  pathway  involves  “death  receptors”  that  
bind tumor necrosis factors (TNF) and induce apoptosis through the activation of caspase-8. 
The intrinsic pathway of apoptosis involves the mitochondria and induces the 
permeabilization of the mitochondrial membrane through the use of Bcl family members. The 
membrane permeabilization releases the enzyme cytochrome c, which promotes caspase 
activation starting with caspase-3, therefore inducing apoptosis7. In a study performed at the 
Heilman laboratory last year, it was shown that although PCV1 VP3 does not show strong co-
 5 
 
localization, it was localized near the mitochondria and therefore it is reasonable to assume 
that PCV1 VP3 is involved in the extrinsic pathway of apoptosis10. 
Although members of the Circoviridae family, such as the protein encoded by the 
ORF3 of CAV, Apoptin, localize to the nucleus in transformed cells, PCV1 VP3 is localized 
in the cytoplasm regardless of whether it has been transfected into a transformed cell or 
primary cell. There are several localization sequences within the third open reading frame of 
PCV1. PCV1 VP3 contains two putative nuclear export signals (NES) and one nuclear 
localization signal (NLS). One NES (amino acids 42-49) is located in the core domain while 
the second NES (amino acids 134-149) is located within the tail domain10. Research has 
shown that truncated PCV1 VP3 has a decreased killing capacity and this prompted the 
question as to how localization signals within the tail domain enhance the  viruses’  ability  to  
induce apoptosis3. 
Nuclear export signals (NES) were first recognized in the HIV 1 Rev protein and the 
cAMP-dependent protein kinase (PKA) polypeptide inhibitor (PK1). Since this identification 
these export sequences have been found to be short, highly hydrophobic, leucine-rich 
residues17. In order for proteins to be exported from the nucleus, multiple factors must come 
together. Chromosome region maintenance 1 (Crm1) is the main receptor for protein export, 
it allows for the  transport  of  various  substrates.  Crm1  contains  α-helices on the outside of its 
structure which its leucine-rich substrates are thought to bind to. Along with binding the 
protein to be exported, Crm1 also binds to RanGTP; this forms a trimeric transport complex 
which transports the desired protein to the cytoplasm11. While PCV1 VP3 has not yet shown 
localization to the nucleus, it does contain two separate export sequences that match the 
canonical sequence required for Crm1 transport. 
The well-characterized protein Apoptin from CAV has been found to be a 
nucleocytoplasmic shuttling protein. Apoptin remains in the cytoplasm of primary cells and it 
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is imported into the nucleus in transformed cells. It is shuttled through the primary 
mechanisms (Crm1 and Ran GTPase) and contains a functional NES and NLS9. While these 
functional  localization  signals  are  imperative  to  Apoptin’s  proper  induction  of  apoptosis  in  
transformed cells, a strong NES in the related PCV2 VP3 also seems to play a role in its 
ability to induce apoptosis. PCV2 has two isoforms, PCV2a and PCV2b. These two forms 
contain functional export sequences within their respective VP3, yet the greater pathogen 
PCV2b contains an extra leucine in the N-terminal NES while the non-pathogenic PCV2a 
contains a phenylalanine instead16. These correlations between the proteins apoptotic ability 
and  a  strong  and  functional  NES  prompts  the  question  of  whether  or  not  PCV1  VP3’s  two  
export sequences are responsible for its potent ability to induce apoptosis in transformed 
cells. 
A connection has been made between export sequences and the ability to induce 
apoptosis. The well- researched Apoptin has shown that simultaneous functionality of both its 
NLS and NES is imperative to its proper localization. However, it has also been shown that 
its NES is crucial for proper multimerization.  This was discovered during experiments to test 
whether or not another functional NES and NLS could be substituted into Apoptin and still 
result in the same localization in transformed and primary cells. While the NLS was 
substituted and proper localization still observed, the substituted NES was not able to provide 
the same functionality. Both the multimerization domain and the export sequence are in the 
N-terminus so it was reasonable to assume that these two sequences overlap and therefore 
changing the exact NES affected Apoptin’s  ability  to  multimerize9.  The proper 
multimerization of Apoptin is crucial for its localization and its ability to induce apoptosis, 
therefore it is reasonable to presume that its relative PCV1 VP3 may also multimerize. 
However, ability of PCV1 VP3 to multimerize and the possible relationship between 
multimerization and the localization signals has yet to be discovered. 
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Through the use of site-directed mutagenesis, this study shall explore the significance 
of the NES in both the tail and the core of PCV1 VP3. Point mutagenesis shall allow for the 
slight mutation of the core and tail export sequences. Through using this technique and 
mutating only a few amino acids, the overall structure of the protein may be maintained and 
the lack of functioning export sequences may be evaluated more accurately. By disabling the 
two export sequences within PCV1 VP3 separately as well as creating a construct including 
both mutated sequences, the functionality of the export sequences may be analyzed and a 
better insight shall be gained as to whether or not these localization sequences play a 
significant role in the cell death of transformed cells. 
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Materials and Methods 
Nuclear Export Sequence (NES) Prediction 
CLC Free Work Bench was used to translate each PCV1 VP3 base pair sequence. The 
amino acid sequence was analyzed with the NESBase 1.0 Protein Sorting NetNES predictor. 
Two NES sequences were detected, the stronger of the two located on the C-terminal end of 
the protein. 
Site-Directed Mutagenesis of NES Sequences 
The forward and reverse primers were engineered to amplify PCV1 VP3 containing 
both EcoR1 and BamH1 restriction sites and tagged with green fluorescent protein (GFP). 
The primers were constructed to mutate the canonical NES sequence found in both the core 
and the tail regions by mutating three hydrophobic leucine residues to alanine residues 
(bolded and underlined). For amplification of the core mutant NES construct, the forward 
primer  sequence  was  5’TAC  AGC  TGT  CTT  CCA  ATC  ACG  GCG GCG CAT GCG CCC 
GCT  CAC  TTT  CAA  AAG  TTC  3’   at amino acid residues 38-56. The reverse primer 
sequence  for  the  core  mutant  was  5’  GAA  CTT  TTG  AAA  GTG  AGC  GGG  CGC ATG 
CGC CGC CGT GAT TGG  AAG  ACA  GCT  GTA  3’.  For  amplification  of  the  tail  mutant  
NES  construct,  the  forward  primer  was  5’  CCA  CTT  CAC  CTT  GTT  AAA  AGT  GCG GCT 
GCT AGC  AAA  ATT  CGC  AAA  CCC  CTG  3’  at  amino  acid  residues  133-149. The reverse 
primer sequence for the core mutant was 5’  CAG  GGG  TTT  GCG  AAT  TTT  GCT  AGC 
AGC CGC ACT  TTT  AAC  AAG  GTG  AAG  TGG  3’. 
Site-Directed Mutagenesis was performed using the QuickChange (Stratagene) PCR 
method. The reaction was run in the thermo cycler under the following conditions: dsDNA 
denaturing (95°C, 5 minutes), primer annealing (55°C, 1 minute), and extension (68°C, 
7minutes). After 20 cycles of this reaction, a final extension time at 68°C for 4 minutes and 
kept at 10°C for storage.  
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Products were confirmed via gel electrophoresis (1 hour, 90V). The PCR template 
was removed by DPN1 restriction; 14μL  of  PCR  products in 1μL  of  DPN1  and heating at 
37°C for 1 hour. 
Transformation of Competent E. Coli 
JM109 Competent E.coli cells (50µL, L2005 Promega) were transformed with the 
restricted PCR products (4µL). The competent cells were incubated for 15 minutes, heat 
shocked for 60 seconds at 42°C and then placed on ice for 2 minutes. LB media (450µL) was 
added to the samples and the cells recovered for 1 hour at 37°C. The transformed E. coli was 
plated onto LB agar plates containing kanamycin and incubated at 37°C overnight (18-24 
hours). 
Small Scale Plasmid Purification 
Four colonies per plate were selected and transferred to pre-warmed LB media 
containing 1000x kanamycin for inoculation. Incubation with vigorous shaking (220rpm) at 
37°C was performed for about 18 hours. Plasmid DNA was then isolated by Wizard®Plus 
Minipreps DNA Purification System (Promega, Madison MI) using the published protocol20. 
The purified DNA was subject to restriction digests to confirm size of DNA constructs.  
Restriction Digest 
Restriction digests of all eluted plasmid DNA were performed with a master mix 
containing BamH1 (9µL), 10u/µL EcoRI (9µL), Buffer E (18µL) and ddH2O (117µL). The 
master mix (17µL) was added to eluted DNA (9µL) in an eppendorf tube and incubated 1 
hour at 37°C. Agarose gel electrophoresis was performed on a 1% gel in order to confirm 
restriction of the eluted DNA. 
DNA Quantification and Sequencing 
The eluted plasmid DNA was diluted 100 fold in ddH2O in order to approximate 
quantification. Absorbance was measured at 260nm and approximate concentrations were 
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calculated to a dilution of 100ng/µL. DNA products were sent to Macrogen USA to be 
sequenced. 
Medium Scale Plasmid Purification (Midi Preparation) 
Overnight cultures were inoculated with transformed E.coli after confirmation of 
sequencing with desired mutations. The cultures incubated for 16-18 hours at 37°C. The 
plasmid  DNA  was  isolated  with  Promega’s  PureYield  Plasmid  Midiprep  System (Madison, 
WI) using the published protocol21. 
Cell Culture Maintenance  
H1299s, non-small human lung carcinoma cells, lacking endogenous P53 were 
maintained  with  Dulbecco’s  Modified  Eagle  Medium  (DMEM)/High  Glucose  with  10%  Fetal  
Bovine Serum and PSF (100 units/mL Pen G sodium; 100 mg/mL streptomycin sulfate; 0.25 
mg/mL amphotericin B). The cells were incubated in 37°C and humidified by 5% CO2 and 
confluence of the cells was maintained at or below 75% by frequent passage.  
Transient Transfection in H1299 Cell Lines and Fluorescence Microscopy 
H1299 cell lines were transiently transfected with PCV1 VP3 mutants, wild- type 
PCV1 VP3 tagged N-terminally with GFP. Each construct contains a constitutive CMV 
promoter to control transfection using Effectene Transfection Reagent Kit (Qiagen) with the 
published protocol. H1299 cells were passed into a 6-well plate with square coverslips at 40-
50% confluence. The H1299 cell line was transfected after approximately 36-48 hours of 
incubation at 70-80% confluence. At approximately 24 hours post-transfection, the media 
was aspirated from the 6-well plate and the cells were washed with 1x PBS and fixed with 
4% paraformaldehyde in PBS with slow agitation for 15 minutes. The cells were washed with 
1x PBS again mounted on slides with mounting media (50% glycerol; 100 mM Tris (pH 7.5); 
2% DABCO, 10µg/mL DAPI), and imaged by epifluorescence and confocal microscopy. 
 
 11 
 
Nuclear/ Cytoplasmic Fraction Determination 
The nuclear/cytoplasmic ratio was calculated for each GFP-tagged construct using 
ImageJ15. The fluorescence intensity of both the nucleus and cytoplasm for each cell was 
calculated using corrected total cell fluorescence (CTCF). This figure was calculated by 
integrated density – (area of selected cell  X mean fluorescence of background readings). The 
average value for three cells was calculated and normalized using the ratio of eGFP. The 
ratios were quantified in a bar graph. 
 The fluorescence images were also used to create a histogram, which quantified pixel 
intensity by distance, which was measured from the inner edge of the nucleus to the cell wall. 
This image allowed quantification of the amount of GFP expression within the nucleus. 
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Results 
The importance of localization sequences within the third open reading frame of 
circoviruses, such as Apoptin of Chicken Anemia Virus (CAV) and Porcine Circovirus 2 
(PCV2), has promoted research of the nuclear export sequences (NES) within Porcine 
Circovirus  1  (PCV1).  Studies  of  Apoptin  proved  that  its  NES  is  critical  for  the  protein’s  
induction of apoptosis within transformed cells. This specificity is of particular importance 
since both Apoptin and PCV1 VP3 induce apoptosis using a p53-independent mechanism. 
The large population of cancer patients lacking functional p53 has created a great need for 
therapies that manipulate p53-independent pathways of cell-death. This study focused on the 
export sequences within PCV1 VP3 to assess their functionality with the aim to gain further 
insight to the mechanism behind its onco-specific activity. 
The importance of export sequences in the induction of apoptosis has been studied in 
homologs of PCV1 VP3, such as Apoptin and PCV2 VP3.  Since the importance of export 
sequences in apoptotic ability of other VP3 Circoviridae members have been extensively 
studied in the Heilman laboratory, the high sequence conservation is a tool that can be used to 
investigate relatively uncharacterized proteins, such as PCV1 VP3. To gain further insight 
regarding the homology between the PCV1 VP3 and PCV2 VP3 on an amino acid level, a 
clustal alignment was performed, shown in Figure 2. This sequence alignment reveals that 
PCV1 VP3 and PCV2 VP3 share approximately 67% homology between amino acids 1-104. 
This conserved area of PCV1 VP3 shall be henceforth referred to as the “core”  domain. 
Analysis of the alignment reveals that a NES, located between amino acids 42-48, is 
conserved within this homologous domain. Previous studies have indicated that this is not the 
only export sequence within PCV1 VP3. 
While PCV1 VP3 and PCV2 VP3 share a high degree of homology, PCV1 VP3 is 
significantly longer, its sequences continues to be almost double the length of PCV2 VP3. 
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Figure 2B displays this unique extension of PCV1 VP3. The alignment shows that PCV2 
VP3 contains a stop codon at amino acid 104 where PCV1 VP3 contains a Tyrosine. This 
explains how PCV2 VP3 is only 104 amino acids long, while PCV1 VP3 contains 206 amino 
acids. This extension of the C-terminal end of PCV1 VP3 shall be henceforth termed the 
“tail”  domain. This highly hydrophobic tail domain is a unique feature and remains largely 
uncharacterized. Interestingly, in previous studies truncation of the PCV1 VP3 tail domain 
proved that the C-terminal half of the protein was involved in the cytoplasmic localization of 
the protein. The next logical step was the use of prediction algorithms to find export 
sequences within that domain. 
A reliable NES prediction algorithm, NetNES predictor, was applied to find the exact 
location of the export sequences within PCV1 VP3. The NetNES algorithm uses a sequence 
alignment from 67 proven export sequences. This website also uses data outputs from 
algorithms, such as the Hidden Markov Model (HMM) and Artificial Neural Network (ANN) 
to prevent incorrect predictions23. This model predicted two export sequences within PCV1 
VP3. As expected the two predicted sequences were found in different regions of the protein, 
as shown in Figure 3. The first and weaker NES was predicted to be in the core domain, a 
region that shares a high degree of homology between the other members of the Circoviridae 
VP3 family. Amino acid L49 received the highest NES score in the core domain (0.407) and 
therefore this amino acid was a target for mutation. The second NES predicted had a NES 
score twice as strong and exceeded the threshold (0.50). This NES is located within the tail 
domain of the protein and is a region of particular interest since it is lacking from the other 
Circoviridae VP3 members, as shown in Figure 4. Leucine residues L140-142 received the 
NES scores 0.105, 0.603 and 0.863 respectively and therefore all three were a target for 
mutation. 
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The NetNES prediction provided the foundation for the construct design of the PCV1 
VP3 NES mutants.  While the predictions provided by this algorithm have been successfully 
used by our lab, the output  was  compared  to  the  published  NES  consensus,  Φ  -X2-3- Φ-X2-3- Φ-
X- Φ,  for  further  confirmation.   Figure 5 displays the NES consensus and the amino acids 
chosen as the target of the site-directed mutagenesis performed in this study. The three amino 
acids were chosen using the information from both the algorithm and the trusted NES 
consensus. Three leucine residues were targeted for each construct due to their predicted role 
in nuclear export. This prediction is supported by the established mechanisms of leucine- rich 
export sequences, such as that of Apoptin, in which leucine residues directly interact in the 
Crm1 pathway. 
The identification of important leucine residues within the export sequences allowed 
for the design of mutated constructs. Alanine was chosen to replace the leucine residues; its 
small size would hinder chemical reactions involving leucine without changing the overall 
structure of the NES. This replacement allowed the specific role of the targeted leucines to be 
analyzed. Two constructs were designed using site-directed mutagenesis; a construct in which 
the core domain NES was mutated (core mutant), the second containing a mutated tail NES 
(tail mutant). The construct with the mutated core NES targeted amino acids 41-49 to ensure 
that the mutation (LLHLAAHA) resulted in loss of function. Likewise, the construct 
containing the mutated tail NES also targeted three leucine residues, but without interruption. 
Amino acids L140-L142 were mutated to A140-A142. To confirm that the primers designed 
would mutate the sequence to lack functional export sequences, the mutated sequence was 
analyzed using the NetNES predictor. As shown in Figure 7, the output confirmed that the 
designed mutations should leave PCV1 VP3 with no functional export sequences. 
The site-directed mutagenesis and amplification of the mutated gene was performed 
using the QuickChange PCR technique. This technique allowed for the incorporation of the 
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desired mismatches, while amplifying the plasmid along with the gene of interest. The PCV1 
VP3 construct fused with GFP on the N-terminus was chosen for mutation in order to track 
the localization of the protein. The PCR product was restricted with DPN1 to digest any 
template methylated DNA, and competent E.coli was transformed with the restricted product 
to repair DNA as well as screen the other constructs. The plasmid was amplified and the 
DNA isolated through the use of a midi preparation. As shown in Figure 8A, the restricted 
and unrestricted products for each construct were analyzed using gel electrophoresis and 
bands were the expected size of 0.6kB and 4.7kb, which corresponds to the size of the full-
length PCV1 VP3 and GFP, respectively. This analysis suggests successful incorporation of 
the primer and no contamination. The success of the site-directed mutagenesis was confirmed 
through sequencing as shown in the electropherograms in Figure 8B. After confirmation of 
the correct mutations in the predicted export sequences, it was necessary to assess the 
exporting ability of the mutated constructs using localization experiments. 
The cytoplasmic localization of PCV1 VP3, regardless of whether it has been 
transfected into transformed or primary cells, has been proven using truncation experiments. 
This differs from the nucleocytoplasmic shuttling protein, Apoptin. This related protein 
localizes to the nucleus in transformed cells while maintaining cytoplasmic localization in 
primary cells. To determine whether the mutated PCV1 VP3 NES constructs resulted in 
partial nuclear localization, H1299s, non-small lung carcinoma cells, were transfected. Figure 
9 shows the fluorescence images using confocal microscopy of the NES core mutant, NES 
tail mutant, and the wild-type PCV1 VP3 all tagged on the N-terminus with GFP. The images 
display non-nuclear localization in transformed cells of both mutated PCV1 VP3 constructs. 
This surprising result suggested that the mutations did not ablate the core and tail domain 
export sequences. To analyze the effects of export compensation within these two mutants, a 
third construct was designed. The same process of site-directed mutagenesis was performed, 
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and both export sequences within the core and tail domain were mutated. The H1299 cells 
transfected with this double mutant, as shown in Figure 9, display the same strong 
cytoplasmic localization that both the core and tail mutants demonstrated. This proved that 
the mutations did not result in loss of function and that compensation was not a factor. The 
strong exporting capability of each mutant may suggest that the prediction algorithms were 
incorrect in determining the NES location or that there are other non-predicted export 
sequences present. 
For further qualitative measurements of the GFP expression, surface plots were 
extrapolated using ImageJ, shown in Figure 10. These topographical maps assist in the 
visualization of the difference in GFP expression of cells transfected with wild-type PCV1 
VP3 compared to a NES tail mutant. It is evident that the localization is completely non-
nuclear for the NES tail mutant, while the wild-type protein has slight GFP expression in the 
nucleus.  
While the qualitative data showed significant evidence of strong cytoplasmic 
localization, this surprising result was further substantiated using quantitative data analysis. 
ImageJ was applied to quantify the localization results, the amount of mean GFP expression 
in the nucleus and cytoplasm was calculated for each construct. This data was translated to a 
bar graph, which displayed the nuclear/cytoplasmic ratio for each construct, as shown in 
Figure 11. The ratio for the positive control, eGFP, was used to normalize the data for each of 
the constructs. To correct for difference in cell size and varying intensities, each ratio was 
calculated from average corrected total cell fluorescence (CTCF) for three cells. The results 
of the bar graph confirm that localization for constructs with mutations within the tail NES 
have a higher intensity in the cytoplasm compared to wild-type PCV1 VP3 and the NES core 
mutant. The data from the construct with mutations in both the core and tail export sequences 
is consistent with the single NES mutants, again confirming that there is no compensation by 
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one export sequence when the other is non-functional. To further investigate the localization, 
Figure 12 shows a histogram graphing the pixel intensity by distance from the nucleus to the 
cell wall for each construct. This image also displays less localization within the nucleus for 
all of mutants, which are surprising results considering that they suggest that exporting ability 
may be enhanced.  
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Discussion  
In the United States alone, over one million people are diagnosed with cancer each 
year24. With this staggering number of people affected, there is increasing pressure to find 
effective cancer treatments. Research that focuses on p53-independent therapies, and 
therefore likely to benefit a larger population of cancer patients is desperately needed. 
Members of the Circoviridae family, including CAV and PCV1, code for proteins that 
demonstrate onco-specific activity as well as p53-independent mechanisms of inducing 
apoptosis. Proteins with such capabilities hold promise for potential cancer treatments. 
The third open reading frame of CAV codes for the well-characterized protein 
Apoptin. It has been found that proper localization of Apoptin within the cell is imperative 
for its induction of apoptosis in cancer cells. In primary cells it is localized to the cytoplasm 
while in transformed cells it localizes to the nucleus. This brought attention to localization 
signals within PCV1 VP3, a protein that remains cytoplasmic in both primary and 
transformed cells. While Apoptin contains one known functional nuclear export sequence 
(NES), PCV1 VP3 contains two putative export sequences as predicted using the NetNES 
predictor. Since export sequences are key factors to the localization and induction of 
apoptosis, our study focused on determining the functionality of both putative export 
sequences in PCV1 VP3. 
The putative NES within the tail domain was predicted to be incredibly powerful and 
there was significant evidence that the three leucine residues targeted by the site-directed 
mutagenesis  performed  were  key  to  the  protein’s  exporting  ability.  While  this  mutation  was  
not expected to result in complete nuclear localization, as this is a largely cytoplasmic 
protein, it was expected that detectable nuclear localization would be observed. However, 
that was not the case; the tail mutant construct expressed strong cytoplasmic localization. 
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This localization revealed that the mutations did not result in loss of functional export 
sequences and considering the evidence provided by alignments and reliable prediction 
software, this was incredibly shocking.  
As surprising as the localization was concerning the tail mutant, the strong 
cytoplasmic localization of the double mutant was even more astonishing. The strongly 
cytoplasmic localization of this double mutant construct proved that the intact core NES of 
the tail mutant construct was not compensating for the mutation. This prompted many 
questions as to the functionality of the predicted export sequences and the biochemistry 
behind this localization 
Closely looking at the mutations made within the tail NES, there is room for 
biochemical compensation. Since the three target leucine residues are adjacent to each other 
and were replaced with three alanine residues, it could be possible that the size and intense 
hydrophobicity of the leucine residues was not a critical factor in the export mechanism. The 
alanine residues may have had enough hydrophobicity in that clumped manner to compensate 
for the lack of leucine residues. The possibility of this compensation could be tested further 
by the replacement of leucine with a more weakly hydrophobic amino acid such as glycine.  
On the other hand, chemical compensation may have nothing to do with the exclusive 
cytoplasmic localization. While the NetNES output predicted that the mutated leucine 
residues were critical, it may have been a false prediction. The NES in both the core and tail 
had two other hydrophobic residues that could have an active role in the nuclear export of 
PCV1 VP3. These remaining residues may have a critical role in the activity of the sequence 
or compensate for the missing leucine residues. Further analysis of these residues may 
provide insight into the mechanism and functionality of these putative export sequences. 
. 
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 While all evidence led this study to focus on the putative export sequences suggested 
by NetNES predictor and their alignment with the classical leucine-rich export sequence, 
these sequences might be non-functional. It is probable that the core NES is too weak to 
contribute to localization, but previous studies performed in the Heilman lab indicate that 
significant localization signals exist within the tail domain. The possibility remains that a 
non-classical export sequence, which would remain undetected by the popular algorithms, 
exists in PCV1 VP3. Non-classical export sequences have been discovered in viral proteins, 
such as feline immunodeficiency virus (FIV) Rev and equine infectious anemia virus (EIAV), 
and certainly deserve future analysis2.  
Further evidence that a non-classical NES lays within the tail domain is supported by 
the fact that this construct lacking key residues in the predicted NES in the tail domain, 
displayed stronger cytoplasmic localization than the wild-type PCV1 VP3. This thought 
provoking result suggests that the site-specific mutation could be enhancing exporting 
capabilities, which would also up-regulate the cytoplasmic localization and possibly the 
apoptotic ability of the virus. The designed constructs lacking functional export sequences 
could be tested further via apoptosis assays to test possible up-regulation of killing capacity. 
If a non-classical export sequence is in fact overlapping the predicted export 
sequence, mutations to a smaller residue, such as alanine, could create more efficient protein 
folding and enhance exporting abilities by making key residues more available for 
localization. The use of alternative methods, such as alignments with non-classical export 
sequences of other viruses, could be used to target other export sequences within the tail. 
Another possible method could be to excise parts of the tail domain into sections to zone in 
on a specific section of the sequence that could possibly contain a non-classical NES. 
While the results of this study were unexpected, they are significant and promote 
many questions about the localization sequences within PCV1 VP3. The identification of 
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active residues within the export sequences will bring us closer to discovering the mechanism 
behind  PCV1  VP3’s  onco-specific activity. Further studies focused on additional mutations to 
the putative export sequences as well as a search for non-classical sequences may shed light 
on this intriguing topic. 
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Figure 2: Amino acid alignment of PCV1, PCV2a and PCV2b VP3 
The alignment produced with MacVector, shows a highly conserved sequence between the 
third viral protein of PCV1, PCV2a and PCV2b in amino acids 1-105 in panel A. The 
elongated tail domain of PCV1 VP3 shown in panel B, extends the amino acid sequence of 
the protein to be almost double the length of PCV2 VP3. 
 
 
Figure 3: NES prediction of PCV1 VP3 using the NetNES prediction software 
The NES score (0-1) determines the likelihood of nucleotides being in the NES if the score is 
over the threshold (0.5).  The statistical markers, such as ANN and HMM, determine that the 
data is statistically relevant and protect from false positives. This image, along with 
quantification data (not shown) determine that there is a putative NES in the core domain at 
42-49 a.a. and a strong putative NES in the tail domain at134-149 a.a..  
A. B. 
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Figure 4: Schematic of localization and export sequences of PCV1 VP3 and homologs 
The spatial alignments display the third open reading frame of PCV1 and its homologs, CAV 
and PCV2. As previously shown, the sequences are well conserved, except the tail domain of 
PCV1 VP3. Characterized proteins such as the CAV protein, Apoptin, allow us to 
hypothesize the presence of localization and export sequences of uncharacterized proteins 
like PCV1 VP3. 
 
 
Figure 5: Primer design using NES Consensus 
Comparison of the NES canonical sequence and the putative NES sequence in the core and 
tail domain of PCV1 VP3. The leucine rich sequences were mutated to alanine residues using 
site-directed mutagenesis to clone a construct with a non-functional NES in the desired 
domain.  
 
Figure  6: Site-directed mutagenesis PCR Product of PCV1 VP3 
The  schematic  outlines  the  process  of  the  PCR  procedure,  which  executes  site-directed  
mutagenesis  with  the  QuikChange  protocol  (Stratagene).  The  mutagenic  primers  are  aligned  
with  each  other  in  reverse  directions,  so  they  are  both  amplified  around  the  entire  plasmid.   
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Figure 7: NES prediction of PCV1-VP3 mutant using the NetNES prediction software 
NES score (0-1) determines the likelihood of nucleotides being in the NES if the score is over 
the threshold (0.5).  This image is the analysis of the sequences with mutations in putative 
export sequences determined by previous data from the NetNES prediction software and the 
NES consensus. The prediction software determined that there are no putative export 
sequences  in  PCV1  VP3  for  the  sequence  with  mutation  of  “predicted”  export  sequences. 
               
Figure 8:  Confirmation of mutated PCV1 VP3 constructs 
(A) Gel electrophoresis of eluted DNA of PCV1 VP3 constructs to confirm no contamination. 
Restriction digests with BamH1 and EcoR1 show the expected band size of 0.6kb and 4.7kb, 
which corresponds to the DNA fragment of the full length PCV1 VP3 and GFP, respectively. 
(U=uncut, C=cut with restriction enzymes) (B) Electropherograms of Δ41-49Δ134-142 
sequence. Further proof of the presence of desired mutations from leucine to alanine residues 
in the both the core (top) and tail (bottom) domains. 
A. B. 
A A 
A 
A 
A A 
 25 
 
 
Figure 9: Fluorescent images of PCV1 VP3 constructs 
The H1299 cell lines were transfected using an Effectene Kit (Qiagen) with four different 
PCV1 VP3 constructs tagged with GFP on the N-terminal end and a positive control, eGFP. 
Confocal microscopy of the fusion proteins with either a mutation in one or both export 
sequence show that the protein remains to be a non-nuclear protein. 
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Figure 10: Surface plots of PCV1 VP3 WT and tail mutant 
The pixel intensity of each confocal image was graphed topographically using ImageJ. This 
tool enables an accurate visualization of the GFP expression in the cell. The PCV1VP3 wild-
type protein (top) confirm cytoplasmic localization with significant GFP expression in the 
nucleus. The plot of the PCV1 VP3 construct Δ134-142 (bottom) confirms that the fusion 
protein is localized in the cytoplasm, even with the mutation in the NES of the tail domain.  
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Figure 11: Localization analysis of PCV1 VP3 constructs 
The nuclear/cytoplasmic fraction was calculated to quantify the results of the confocal 
images. The mean green intensity in the nucleus and cytoplasm of three cells for each 
construct was measured and the average was used for quantification. The graph confirms 
strong cytoplasmic localization of the wild-type as well as the mutated PCV1 VP3 constructs. 
 
 
Figure 12: Histogram detailing GFP expression in H1299 cells 
The fluorescent images were analyzed using ImageJ. The amount of pixel intensity for each 
cell was measured from the inner edge of the nucleus to the cell wall. The red divide marks 
the area of GFP expression within the nucleus (left) and cytoplasm (right). The mutated 
constructs are barely detectable within the nucleus but display strong perinuclear localization. 
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